Medical News

RSS

Call for greater scrutiny of relationship between medical journalists and health care industry

The BMJ paper outlines three areas where journalists might become entangled in conflict-of-interest issues: during educational activities that may be drug company sponsored, when accepting sponsored awards, or in the day-to-day practice of reporting the news by relying too heavily on industry supplied sources.

19 Nov 2008

Results out from first phase III randomized clinical trial to study the best time to begin ART in infants

Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine.

19 Nov 2008

Breakthrough could revolutionise drug development

Scientists in Leeds have devised a new way to create the next generation of man-made molecules in a breakthrough that could revolutionise drug development.

19 Nov 2008

Acute kidney injury predisposes elderly to serious kidney disease

Acute kidney injury (AKI) - which is often caused by trauma, illness, or surgery - predisposes elderly individuals to the most serious form of chronic kidney disease (CKD), known as end stage renal disease (ESRD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN).

19 Nov 2008

KAI Pharmaceuticals reports positive results for KAI-1678 in pain reduction

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced preclinical results demonstrating the effectiveness of KAI-1678 in reversing pain (hyperalgesia and allodynia) in multiple preclinical models.

19 Nov 2008

Researchers define ideal time for stem cell collection for Parkinson's disease therapy

Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience.

19 Nov 2008

A new Institute for Nanotechnology

The George Washington University has announced the establishment of the GW Institute for Nanotechnology.

19 Nov 2008

Gentium S.p.A. updates on phase 3 trial of Defibrotide for severe veno-occlusive disease

Gentium S.p.A. announced today interim results from an independent Data Safety Monitoring Board (DSMB) review of the Company's Phase 3 treatment trial of Defibrotide for Severe Veno-Occlusive Disease (VOD).

19 Nov 2008

Genetic screening no better than traditional risk factors for predicting type 2 diabetes

Screening for a panel of gene variants associated with the risk for type 2 diabetes can identify adults at risk for the disorder but is not significantly better than assessment based on traditional risk factors such as weight, blood pressure and blood sugar levels.

19 Nov 2008

First trachea transplant and first tissue transplant without immunosuppression

After 4 years of going from consultation to consultation, Claudia Castillo finally found a solution to her respiratory problems.

19 Nov 2008

Household budget cutbacks in health care could have serious consequences

Household budget cutbacks are becoming commonplace as most Americans struggle to make ends meet, but experts warn that health care needs should not be among the forfeited services.

19 Nov 2008

Enzyme discovery may lead to better heart and stroke treatments

A Queen's University study sheds new light on the way one of our cell enzymes, implicated in causing tissue damage after heart attacks and strokes, is normally kept under control.

19 Nov 2008

Deep brain mapping to pinpoint specific are of brain associated with Gulf War syndrome

Researchers at Southern Methodist University in Dallas are pioneering the use of spatial statistical modeling to analyze brain scan data from Persian Gulf War veterans, aiming to pinpoint specific areas of the their brains affected by Gulf War Syndrome.

19 Nov 2008

Launch of new safety hypodermic needle

Covidien has announced that it is launching a new and improved Magellan Safety Hypodermic Needle.

19 Nov 2008

REOLYSIN shown to benefit some sarcoma patients

New data shows that some sarcoma patients are benefiting from treatment with REOLYSIN, developed from a harmless virus called the reovirus that most people are exposed to at some point in their lives.

19 Nov 2008

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phase 2 clinical study of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in patients with newly diagnosed acute myeloid leukemia (AML).

19 Nov 2008

Computational model provides insight into function of brain's visual cortex

Computational neuroscientists at Carnegie Mellon University have developed a computational model that provides insight into the function of the brain's visual cortex and the information processing that enables people to perceive contours and surfaces, and understand what they see in the world around them.

19 Nov 2008

Biomedical research could benefit from deep sea

A study published in the scientific journal PLoS ONE highlights how the exploration of the ocean depths can benefit humankind.

19 Nov 2008

Scientists identify biomarkers for chronological and physiological age prediction

Scientists at the Buck Institute for Age Research have identified for the first time biomarkers of aging which are highly predictive of both chronological and physiological age.

19 Nov 2008

Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges

Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets.

19 Nov 2008

Medical News

Call for greater scrutiny of relationship between medical journalists and health care industry

Results out from first phase III randomized clinical trial to study the best time to begin ART in infants

Breakthrough could revolutionise drug development

Acute kidney injury predisposes elderly to serious kidney disease

KAI Pharmaceuticals reports positive results for KAI-1678 in pain reduction

Researchers define ideal time for stem cell collection for Parkinson's disease therapy

A new Institute for Nanotechnology

Gentium S.p.A. updates on phase 3 trial of Defibrotide for severe veno-occlusive disease

Genetic screening no better than traditional risk factors for predicting type 2 diabetes

First trachea transplant and first tissue transplant without immunosuppression

Household budget cutbacks in health care could have serious consequences

Enzyme discovery may lead to better heart and stroke treatments

Deep brain mapping to pinpoint specific are of brain associated with Gulf War syndrome

Launch of new safety hypodermic needle

REOLYSIN shown to benefit some sarcoma patients

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Computational model provides insight into function of brain's visual cortex

Biomedical research could benefit from deep sea

Scientists identify biomarkers for chronological and physiological age prediction

Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News